Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 12”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Testing effectiveness (Phase 2)Study completedNCT04388254
What this trial is testing

Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 220
Not applicableStudy completedNCT05637801
What this trial is testing

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

Who this might be right for
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+32 more
Cognito Therapeutics, Inc. 673
Testing effectiveness (Phase 2)Ended earlyNCT02249351
What this trial is testing

Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 54
Testing effectiveness (Phase 2)Study completedNCT02471196
What this trial is testing

Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Orion Corporation, Orion Pharma 308
Testing effectiveness (Phase 2)Study completedNCT01602393
What this trial is testing

Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Prolonged Open Label Extension Phase

Who this might be right for
Alzheimer's Disease
Chiesi Farmaceutici S.p.A. 51
Testing effectiveness (Phase 2)Looking for participantsNCT06362707
What this trial is testing

Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)

Who this might be right for
Cognitive Decline, MildAlzheimer Disease
Helse Stavanger HF 200
Large-scale testing (Phase 3)WithdrawnNCT01211782
What this trial is testing

AC-1204 Long-term Efficacy Response Trial (ALERT Protocol)

Who this might be right for
Alzheimer's Disease
Cerecin
Post-approval studies (Phase 4)WithdrawnNCT00711204
What this trial is testing

Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease

Who this might be right for
Severe Alzheimer's Disease
Eisai Inc.
Post-approval studies (Phase 4)Study completedNCT01841125
What this trial is testing

Escitalopram for the Treatment of Depression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Konkuk University Medical Center 84
Testing effectiveness (Phase 2)Study completedNCT02244541
What this trial is testing

Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Anavex Life Sciences Corp. 32
Large-scale testing (Phase 3)Study completedNCT03446001
What this trial is testing

Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment

Who this might be right for
Alzheimer Disease
TauRx Therapeutics Ltd 598
Large-scale testing (Phase 3)Ended earlyNCT02586909
What this trial is testing

12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension

Who this might be right for
Alzheimer's Disease
Axovant Sciences Ltd. 1,099
Testing effectiveness (Phase 2)Study completedNCT02423122
What this trial is testing

A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment
EIP Pharma Inc 16
Large-scale testing (Phase 3)Study completedNCT01862640
What this trial is testing

A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation

Who this might be right for
Agitation Associated WithAlzheimer's DiseaseAlzheimer's Type+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 433
Testing effectiveness (Phase 2)Study completedNCT02249403
What this trial is testing

Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 362
Not applicableStudy completedNCT02860338
What this trial is testing

COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE

Who this might be right for
Mild Cognitive ImpairmentDementiaHypoxia+14 more
Clionsky Neuro Systems Inc. 900
Early research (Phase 1)Study completedNCT03277573
What this trial is testing

Salsalate in Patients Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Adam Boxer 40
Testing effectiveness (Phase 2)Study completedNCT00501111
What this trial is testing

Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
AstraZeneca 659
Post-approval studies (Phase 4)Study completedNCT00234637
What this trial is testing

Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment

Who this might be right for
Alzheimer's Disease
Novartis 204
Not applicableStudy completedNCT01608061
What this trial is testing

ADvance DBS-f in Patients With Mild Probable Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Functional Neuromodulation Ltd 42
Next Page